John Byon
Fortune : 5 407 $ au 31/05/2026
Fortune : 5 407 $ au 31/05/2026
John Byon currently works at Imugene Ltd., as Chief Medical Officer from 2025.
Dr. Byon also formerly worked at Fate Therapeutics, Inc., as Vice President-Clinical Development.
Dr. Byon received his undergraduate degree from Massachusetts Institute of Technology and doctorate degree from Tulane University (Louisiana).
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMUGENE LTD 0,02 % | 30/06/2025 | 65 348 ( 0,02 % ) | 5 407 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IMUGENE LIMITED | Directeur Technique/Scientifique/R&D | 01/09/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| FATE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Imugene Ltd.
Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Tulane University (Louisiana)
Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national